Neil Cashman

CIK: 0001927064

Transaction Breakdown

Open Market Buys (P)2 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PMN

ProMIS Neurosciences Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

PMN
ProMIS Neurosciences Inc.
Nov 2, 2026
Purchase(P)
Direct
10K shares at avg. $3.86$39K
PMN
ProMIS Neurosciences Inc.
May 20, 2026
Award(A)
Option (right to buy)
Direct
50K shares-
PMN
ProMIS Neurosciences Inc.
Feb 3, 2026
Award(A)
Indirect
4.1K shares at avg. $12.13$50K
PMN
ProMIS Neurosciences Inc.
Sep 22, 2025
Award(A)
Option (right to buy)
Direct
165K shares-
PMN
ProMIS Neurosciences Inc.
Feb 10, 2025
Purchase(P)
Indirect
15K shares at avg. $0.97$15K
PMN
ProMIS Neurosciences Inc.
Nov 18, 2024
Award(A)
Option (right to buy)
Direct
200K shares-

		Type	Shares	Price		Ownership
Nov 2, 2026	PMN ProMIS Neurosciences Inc.	Purchase(P)	10,000	$3.86	$38,600	Direct
May 20, 2026	PMN ProMIS Neurosciences Inc.	Award(A) Option (right to buy)	50,000	-	-	Direct
Feb 3, 2026	PMN ProMIS Neurosciences Inc.	Award(A)	4,122	$12.13	$50,000	Indirect
Sep 22, 2025	PMN ProMIS Neurosciences Inc.	Award(A) Option (right to buy)	165,000	-	-	Direct
Feb 10, 2025	PMN ProMIS Neurosciences Inc.	Purchase(P)	15,000	$0.97	$14,595	Indirect
Nov 18, 2024	PMN ProMIS Neurosciences Inc.	Award(A) Option (right to buy)	200,000	-	-	Direct

1-6 of 6 transactions

About Cashman Neil

Cashman Neil (SEC CIK 0001927064) files insider reports with the SEC as Chief Scientific Officer of ProMIS Neurosciences Inc. (PMN).

Signal8 holds 6 ownership filings by Cashman Neil, all Form 4s, filed between Nov 20, 2024 and Nov 3, 2026. Those filings report 6 transactions, from Nov 18, 2024 to Nov 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Cashman Neil's filings is in TORONTO.

Recent filings by Cashman Neil

Nov 2, 2026: Open-market purchase of PMN shares (Form 4, code P).
May 20, 2026: Grant or award of PMN derivative securities (Form 4, code A).
Feb 3, 2026: Grant or award of PMN shares (Form 4, code A).
Sep 22, 2025: Grant or award of PMN derivative securities (Form 4, code A).
Feb 10, 2025: Open-market purchase of PMN shares (Form 4, code P).

Other insiders filing for ProMIS Neurosciences Inc. (PMN)

Williams Eugene, Director
Rubino Ivana, Chief Commercial Officer
Kaplan Johanne, Chief Development Officer
WYMAN WILLIAM W, Director
Warma Neil K, Chief Executive Officer
Shafmaster Madge K., Director

How to read Form 4 transaction codes